NO157453C - Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 6,16-dimethylkortikoider. - Google Patents

Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 6,16-dimethylkortikoider.

Info

Publication number
NO157453C
NO157453C NO832609A NO832609A NO157453C NO 157453 C NO157453 C NO 157453C NO 832609 A NO832609 A NO 832609A NO 832609 A NO832609 A NO 832609A NO 157453 C NO157453 C NO 157453C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically active
new therapeutically
analogy procedure
corticoids
Prior art date
Application number
NO832609A
Other languages
English (en)
Other versions
NO157453B (no
NO832609L (no
Inventor
Klaus Annen
Henry Laurent
Helmut Hofmeister
Rudolf Wiechert
Michael Toepert
Hans Wendt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO832609L publication Critical patent/NO832609L/no
Publication of NO157453B publication Critical patent/NO157453B/no
Publication of NO157453C publication Critical patent/NO157453C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
NO832609A 1982-07-19 1983-07-18 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 6,16-dimethylkortikoider. NO157453C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3227312A DE3227312A1 (de) 1982-07-19 1982-07-19 Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung

Publications (3)

Publication Number Publication Date
NO832609L NO832609L (no) 1984-01-20
NO157453B NO157453B (no) 1987-12-14
NO157453C true NO157453C (no) 1988-03-23

Family

ID=6168986

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832609A NO157453C (no) 1982-07-19 1983-07-18 Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 6,16-dimethylkortikoider.

Country Status (23)

Country Link
US (2) US4555507A (no)
EP (1) EP0100874B1 (no)
JP (1) JPS5967298A (no)
AT (1) ATE50780T1 (no)
AU (1) AU1694183A (no)
BG (2) BG43693A3 (no)
CA (1) CA1312856C (no)
DD (1) DD214134A5 (no)
DE (2) DE3227312A1 (no)
DK (1) DK162232C (no)
ES (1) ES524238A0 (no)
FI (1) FI832575A (no)
GB (1) GB2124230A (no)
GR (1) GR78902B (no)
HU (1) HU191539B (no)
IE (1) IE55771B1 (no)
IL (1) IL69230A (no)
NO (1) NO157453C (no)
PH (1) PH19976A (no)
PL (1) PL141537B1 (no)
PT (1) PT76995B (no)
RO (4) RO92856A (no)
ZA (1) ZA835249B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung
DE3400188A1 (de) * 1984-01-02 1985-07-11 Schering AG, Berlin und Bergkamen, 1000 Berlin Neue 6(alpha),16(alpha)-dimethylkortikoide
DE3401680A1 (de) * 1984-01-16 1985-07-18 Schering AG, 1000 Berlin und 4709 Bergkamen 6(alpha),16ss-dimethylkortikoide
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
US5319115A (en) * 1987-08-25 1994-06-07 Cocensys Inc. Method for making 3α-hydroxy, 3β-substituted-pregnanes
US4866050A (en) * 1988-04-27 1989-09-12 Ben Amoz Daniel Ultrasonic transdermal application of steroid compositions
DE3915951C1 (no) * 1989-05-12 1990-09-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
EP0523132A1 (en) * 1990-03-27 1993-01-20 Schering Corporation PROCESS FOR 9$g(a)-HYDROXY STEROID DEHYDRATION
FR2701262B1 (fr) * 1993-02-05 1995-03-24 Roussel Uclaf Nouveau procédé de préparation de stéroïdes 6 alpa, 9 alpha-difluorés et nouveaus intermédiaires.
DE4333920A1 (de) * 1993-10-05 1995-04-13 Hoechst Ag Corticoid-17,21-dicarbonsäureester sowie Corticosteroid-17-carbonsäureester-21-kohlensäureester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US5502222A (en) * 1994-06-01 1996-03-26 Schering Corporation Process for preparing delta 9,11 and 21-chloro corticosteroids
KR101591482B1 (ko) 2008-05-28 2016-02-03 레베라겐 바이오파마 인코포레이티드 질환의 치료를 위한 ＮＦ-κＢ 의 비호르몬성 스테로이드 조절제
EP2556083A4 (en) 2010-04-05 2013-12-04 Validus Biopharma Inc NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU75903A1 (no) * 1976-09-29 1978-05-16
GB931224A (en) * 1958-10-01 1963-07-17 Merck & Co Inc Steroid compounds and their production
GB898295A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
DE1195748B (de) * 1961-06-24 1965-07-01 Vismara Francesco Spa Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
US3054811A (en) * 1961-09-14 1962-09-18 Merck & Co Inc Ring a unsaturated 6, 16-dimethyl steroids of the pregnane series
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
GB1047519A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡,21-diesters of 11,17,21-trihydroxy steroid compounds
GB1544642A (en) * 1976-06-04 1979-04-25 Bristol Myers Co 9,11-epoxy steroids and synthesis of corticosteroids therefrom
DE2645105C2 (de) * 1976-10-04 1986-03-13 Schering AG, 1000 Berlin und 4709 Bergkamen Derivate des 9-Chlorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2715854A1 (de) * 1977-04-06 1978-10-19 Schering Ag Verfahren zur herstellung von 11alpha,21-dihydroxy-1,4-pregnadien- 3,20-dion-derivaten
US4086254A (en) * 1977-04-13 1978-04-25 The Upjohn Company Photocleavable steroids
DE2759135A1 (de) * 1977-12-30 1979-07-19 Lark Spa Neue steroidverbindungen und deren herstellung und verwendung
US4154748A (en) * 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
DE2803661A1 (de) * 1978-01-25 1979-07-26 Schering Ag Neue in 17-position substituierte 11beta-hydroxysteroide der pregnanreihe, ihre herstellung und verwendung
DE2901561A1 (de) * 1979-01-12 1980-07-31 Schering Ag Verfahren zur herstellung von 11 beta, 17 alpha, 21-trihydroxy-4-pregnen-3,20dion-derivaten
EP0054786B1 (de) * 1980-12-23 1985-03-20 Schering Aktiengesellschaft Neue 6-alpha-Methylhydrocortison-Derivate, ihre Herstellung und Verwendung
DE3227312A1 (de) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 6,16-dimethylkortikoide, ihre herstellung und verwendung

Also Published As

Publication number Publication date
EP0100874A2 (de) 1984-02-22
ZA835249B (en) 1984-03-28
DK329183D0 (da) 1983-07-18
DD214134A5 (de) 1984-10-03
PT76995A (de) 1983-08-01
DK329183A (da) 1984-01-20
EP0100874B1 (de) 1990-03-07
ATE50780T1 (de) 1990-03-15
RO92855A (ro) 1987-11-30
BG43693A3 (en) 1988-07-15
DE3381291D1 (de) 1990-04-12
GB2124230A (en) 1984-02-15
ES8403929A1 (es) 1984-04-16
GB8319363D0 (en) 1983-08-17
RO92856A (ro) 1987-11-30
FI832575A0 (fi) 1983-07-14
EP0100874A3 (en) 1985-04-17
IE55771B1 (en) 1991-01-16
BG43692A3 (en) 1988-07-15
US4701451A (en) 1987-10-20
IL69230A0 (en) 1983-11-30
NO157453B (no) 1987-12-14
AU1694183A (en) 1984-01-26
DK162232C (da) 1992-03-02
GR78902B (no) 1984-10-02
ES524238A0 (es) 1984-04-16
CA1312856C (en) 1993-01-19
JPS5967298A (ja) 1984-04-16
PL141537B1 (en) 1987-08-31
RO92853B1 (ro) 1987-12-01
US4555507A (en) 1985-11-26
JPH0415239B2 (no) 1992-03-17
RO92853A2 (ro) 1987-11-30
HU191539B (en) 1987-03-30
DK162232B (da) 1991-09-30
NO832609L (no) 1984-01-20
FI832575A (fi) 1984-01-20
IL69230A (en) 1988-07-31
IE831658L (en) 1984-01-19
RO92854A (ro) 1987-11-30
PH19976A (en) 1986-08-26
PL243082A1 (en) 1984-11-19
PT76995B (de) 1986-01-09
DE3227312A1 (de) 1984-01-19

Similar Documents

Publication Publication Date Title
NO157453C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 6,16-dimethylkortikoider.
NO156203C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 6alfa-methylprednisolon-derivater.
ES8100273A1 (es) Procedimiento para la preparacion de nuevos derivados de alfa-(3,4-diclorofenil)-2-imidazolina-2-metanol y alfa-(3,4-diclorofenil)-1,4,5,6-tetrahidro-2-pirimidinametanol
JPS57203079A (en) Novel benzofuran derivative, manufacture and antiinflammatory medicine containing same
NO157454C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6alfa-methylkortikoider.
ATE62692T1 (de) 6-alpha,16-beta-dimethylkortikoide.
ATE58145T1 (de) Neue 6alpha, 16alpha-dimethylkortikoide.
NO156409C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6aaa-methylhydrocortisonderivater.
AU562182B2 (en) Bicyclo(4,2,0)1,3,5-octatriene derivatives
AU1112483A (en) Substituted thienobenzodiazepinones
ZA811585B (en) Anti-inflammatory compositions